A Multicenter RWS Study Comparing the Benefits of Continued Use of OFS After 5 Years
Condition: To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast Cancer After 5 Years Interventions: Drug: OFS continues to use group after 5 years; Diagnostic Test: Immunohistochemical detection of HR status Sponsor: Hongmei Zheng Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials